Barclays’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.87M Sell
90,938
-163,902
-64% -$3.69M ﹤0.01% 2390
2025
Q4
$6.04M Buy
254,840
+18,235
+8% +$444K ﹤0.01% 2064
2025
Q3
$5.89M Sell
236,605
-48,314
-17% -$1.04M ﹤0.01% 2066
2025
Q2
$6.55M Buy
284,919
+99,322
+54% +$2.3M ﹤0.01% 1889
2025
Q1
$4.17M Sell
185,597
-34,643
-16% -$805K ﹤0.01% 2057
2024
Q4
$4.31M Sell
220,240
-3,778
-2% -$74.9K ﹤0.01% 2292
2024
Q3
$4.08M Buy
224,018
+158,188
+240% +$3.02M ﹤0.01% 2260
2024
Q2
$1.14M Sell
65,830
-52,988
-45% -$939K ﹤0.01% 2521
2024
Q1
$2.33M Sell
118,818
-81,184
-41% -$1.71M ﹤0.01% 2446
2023
Q4
$4.61M Buy
200,002
+130,457
+188% +$2.92M ﹤0.01% 2167
2023
Q3
$1.6M Buy
69,545
+13,656
+24% +$347K ﹤0.01% 2022
2023
Q2
$1.46M Sell
55,889
-981
-2% -$25.9K ﹤0.01% 2081
2023
Q1
$1.57M Buy
56,870
+16,421
+41% +$433K ﹤0.01% 2378
2022
Q4
$919K Buy
40,449
+9,672
+31% +$269K ﹤0.01% 2879
2022
Q3
$1.05M Buy
30,777
+20,967
+214% +$775K ﹤0.01% 2195
2022
Q2
$285K Sell
9,810
-69,140
-88% -$1.76M ﹤0.01% 3229
2022
Q1
$2.11M Buy
+78,950
New +$1.86M ﹤0.01% 1824

Other funds holding PRVA